Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis

E-ISSN： 0300-7995|22|1|41-48

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.1, 2006-01, pp. : 41-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms

By Serels Scott R. Toglia Marc R. Forero-Schwanhaeuser Sergio He Weizhong

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2277-2285

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley Cardozo Linda

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom

By Hart Warren Mark Abrams Paul Munro Vicki Retsa Peny Nazir Jameel

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1246-1254

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of mirabegron as ‘add‐on’ therapy in patients with overactive bladder treated with solifenacin: a post‐marketing, open‐label study in Japan (MILAI study)

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative Effectiveness of Combined Low- and Standard-Dose Trospium and Solifenacin for Moderate Overactive Bladder Symptoms in Elderly Men and Women

Urologia Internationalis, Vol. 93, Iss. 4, 2014-08 ,pp. : 470-473

Karger

Access to resources Recommend Favorite